0001399529-21-000164.txt : 20211214
0001399529-21-000164.hdr.sgml : 20211214
20211214210221
ACCESSION NUMBER: 0001399529-21-000164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211213
FILED AS OF DATE: 20211214
DATE AS OF CHANGE: 20211214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciappenelli Robert D.
CENTRAL INDEX KEY: 0001778786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 211492697
MAIL ADDRESS:
STREET 1: DICERNA PHARMACEUTICALS, INC.
STREET 2: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
wf-form4_163953372606162.xml
FORM 4
X0306
4
2021-12-13
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001778786
Ciappenelli Robert D.
C/O DICERNA PHARMACEUTICALS, INC.
75 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Strategy Officer
Common Stock
2021-12-13
4
M
0
8856
22.58
A
12629
D
Employee Stock Option (Right to Buy)
22.58
2021-12-13
4
M
0
8856
0
D
2030-01-07
Common Stock
8856.0
76144
D
The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date.
/s/ Douglas W. Pagan, attorney-in-fact
2021-12-14